'The National Health Service is eyeing the cessation of the incessant prescription of Liothyronine, a drug that is used to treat thyroid disorders, after its manufacturer, Oakville, Canada-based pharmaceutical company Concordia International, increased its retail price by 5,662 percent to 9.22 British pounds from 16 p per tablet.
Liothyronine is used to treat hypothyroidism or underactive thyroid, which affects 15 in every 1,000 women and one in every 1,000 men in the United Kingdom. Hypothyroidism is characterized by a poor ability to tolerate cold, constipation, a feeling of tiredness, depression, and weight gain.
An underactive thyroid means your thyroid doesn’t produce enough hormone, and can be caused by many things, including lifestyle. In more severe cases, it can occur when the immune system attacks the thyroid gland and damages it, or when the thyroid sustains damage that was caused by treatments for an overactive thyroid or thyroid cancer.
As there is only one supplier of Liothyronine, patients could be forced to go all the way to Europe, where a packet costs only around a few euros.'
Read more: Big Pharma greed strikes again: “Life-changing” thyroid pill manufacturer spikes price by 5,000%
Did you like this article?
Thank you for your vote!
11 November 2018
Profiteers of Misery: Parents slam health fat cats in UK and US who are raking in as much as £730,000 annually for every autistic child they ‘lock up’ in secretive secure psychiatric units
2 November 2018
American firms should run hospitals for profit after Brexit, says group supported by Trade minister
30 October 2018
Is this why the Tories are ditching PFI? Brand-new £24 million health centre will NEVER be used by NHS patients
From our advertisers
15 hours ago
CIA ‘concludes with high confidence’ Saudi Crown Prince ordered Khashoggi murder – reports
16 November 2018
Psychologists Call Out Tech Industry and the Psychologists They Hire to Design Programs to Hook Kids on Tech
14 hours ago
‘Migrant tsunami’: Tijuana mayor threatens to deport US-bound migrants amid tensions & clashes
From our advertisers